Aerovate Therapeutics, Inc. (AVTE)
NASDAQ: AVTE · Real-Time Price · USD
2.370
-0.020 (-0.84%)
Feb 21, 2025, 4:00 PM EST - Market closed
Aerovate Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Feb '25 Feb 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 68 | 626 | 721 | 288 | - | - |
| Market Cap Growth | -83.92% | -13.15% | 150.50% | - | - | - |
| Enterprise Value | -20 | 492 | 580 | 108 | - | - |
| Last Close Price | 2.37 | 22.63 | 29.30 | 11.79 | - | - |
| PB Ratio | 0.85 | 5.72 | 5.69 | 1.67 | - | - |
| P/TBV Ratio | 0.75 | 5.72 | 5.69 | 1.67 | - | - |
| Debt / Equity Ratio | 0.01 | 0.01 | 0.01 | 0.00 | - | 7.00 |
| Quick Ratio | 8.60 | 6.94 | 16.60 | 65.64 | 2.58 | 5.35 |
| Current Ratio | 8.78 | 7.04 | 16.90 | 68.37 | 2.64 | 5.35 |
| Return on Equity (ROE) | -82.06% | -63.95% | -34.44% | -26.19% | -582.84% | - |
| Return on Assets (ROA) | -48.67% | -38.73% | -21.42% | -15.98% | -135.03% | - |
| Return on Capital (ROIC) | -54.36% | -42.76% | -22.12% | -16.36% | -191.64% | - |
| Earnings Yield | -123.64% | -12.06% | -7.15% | -7.98% | - | - |
| FCF Yield | -109.62% | -9.09% | -5.45% | -9.58% | - | - |
| Buyback Yield / Dilution | -10.95% | -7.60% | -99.06% | -4975.15% | -0.32% | - |
| Total Shareholder Return | -10.95% | -7.60% | -99.06% | -4975.15% | -0.32% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.